Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Alessandro Dinoto(University of Verona), Eoin P. Flanagan(Mayo Clinic in Arizona), A. Sebastian López‐Chiriboga, Misha Pless, Nisa Vorasoot(Khon Kaen University), Stephanie B. Syc‐Mazurek(Mayo Clinic), Eric Eggenberger(Michigan State University), Smathorn Thakolwiboon(Wheaton Franciscan Healthcare), Deena Tajfirouz(Anna Needs Neuroblastoma Answers), Cristina Valencia-Sánchez(Mayo Clinic in Arizona), Nanthaya Tisavipat(Mayo Clinic in Arizona), Vyanka Redenbaugh(Mayo Clinic), Kevin D. Chodnicki(Mayo Clinic), John J. Chen(Mayo Clinic in Arizona), Sean J. Pittock(Mayo Clinic), Susan E. Horsman(Mayo Clinic), Kai Guo(Mayo Clinic), Jan-Mendelt Tillema(Mayo Clinic), Jayawant N. Mandrekar(Cancer Research And Biostatistics), Laura Cacciaguerra(Vita-Salute San Raffaele University)
Cited by 12
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
|Annals of Neurology|2018|758